Russ joined British Patient Capital as an independent Non-executive Director in June 2018 and was appointed Chair on 1 September 2020.
Russ is the former Chief Executive Officer of Touchstone Innovations plc, one of the UK’s leading technology investment companies, championing outstanding science by commercialising innovative research from UK universities. Russ joined as Chief Investment Officer in 2006, then became CEO in 2013 through to the acquisition of Touchstone in 2017 by IP Group plc for £500m.
From 2003 to 2006 he was a Director at the growth equity and venture capital firm Scottish Equity Partners LLP. Prior to this he spent 16 years at the international venture capital and private equity company 3i Group plc, latterly as Director in its UK Technology Group.
Judith is Chief Executive Officer of British Patient Capital and British Business Investments, the British Business Bank’s two commercial subsidiaries, and took up the role on 1 September 2020. Judith previously held the position of Managing Director of the Bank’s UK Network, a team that is physically located within each of the English regions and the three Devolved Nations.
Judith built a career in corporate banking with Barclays and the Bank of Scotland before becoming involved in the delivery of publicly funded access to finance products. Judith was previously the British Business Bank’s Managing Director, Lending Solutions, where she was responsible for the delivery of a number of the Bank’s debt-based products, including the Enterprise Finance Guarantee, Help to Grow and Start Up Loans. Judith joined the Bank from Capital for Enterprise where she was Managing Director, Debt Markets.
Catherine was appointed Executive Director of British Patient Capital in September 2020 upon her appointment as CEO of the British Business Bank. Prior to this, since 2016 Catherine has led the Bank’s commercial arm as CEO of British Business Investments (BBI), and from October 2018 of both BBI and British Patient Capital.
Prior to 2016, Catherine was Head of Private Equity for Cardano Risk Management, managing a global portfolio of private capital investments on behalf of UK pension funds. She was previously Managing Director of Paris-based European private equity investor Fondinvest Capital, a founding partner of Nordic fund-of-funds manager Proventure, after which she established a consultancy business advising Sovereign Wealth Funds and Institutional Investors in Asia, the Middle East and the US on their European private capital strategies.
Hazel joined British Patient Capital as an independent Non-executive Director in June 2019.
Hazel is the co-founder and Chair of FirstCapital, an investment bank which provides mergers and acquisitions, private equity and growth capital advice to high-growth technology companies. She also currently chairs the Innovation Finance Sub-Committee for Innovate UK, the UK’s national innovation agency, having been a Governing Board member of Innovate UK until 2018. Hazel is a member of the Future Fifty advisory panel and was previously on the Investment Advisory Panel of the North West Fund.
Hazel was awarded an OBE in the 2017 New Years’ Honours list for services to entrepreneurship and innovation. She won the CBI/Real Business First Women in Finance award in 2016 and the Women in Private Equity Award for Best Corporate Finance Adviser in 2015.